SARS-CoV-2 infection in patients with β-thalassemia: Experience from Lebanon.
作者信息
Bou-Fakhredin Rayan, Daadaa Hisham, Koussa Suzanne, Abou Nasr Therese, Noun Peter, Taher Ali T
机构信息
Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Chronic Care Center, Hazmieh, Lebanon.
出版信息
Am J Hematol. 2021 Aug 1;96(8):E285-E288. doi: 10.1002/ajh.26211. Epub 2021 May 13.
Abstract
摘要
相似文献
1
SARS-CoV-2 infection in patients with β-thalassemia: Experience from Lebanon.β地中海贫血患者的新型冠状病毒2型感染：来自黎巴嫩的经验
Am J Hematol. 2021 Aug 1;96(8):E285-E288. doi: 10.1002/ajh.26211. Epub 2021 May 13.
2
Management of non-transfusion-dependent β-thalassemia (NTDT): The next 5 years.非输血依赖型β地中海贫血（NTDT）的管理：未来5年
Am J Hematol. 2021 Mar 1;96(3):E57-E59. doi: 10.1002/ajh.26055. Epub 2020 Dec 9.
3
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia.一名β地中海贫血患者在接种新冠病毒疫苗和使用罗特西普后出现急性肝损伤
Ann Hematol. 2024 Mar;103(3):1025-1026. doi: 10.1007/s00277-023-05591-x. Epub 2024 Jan 3.
4
β-Thalassemias.β地中海贫血
N Engl J Med. 2021 Feb 25;384(8):727-743. doi: 10.1056/NEJMra2021838.
5
Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience.接受地拉罗司治疗的重型β地中海贫血患者的肾结石：是偶然现象还是不良事件？希腊单一中心经验
Ann Hematol. 2013 Jan;92(2):263-5. doi: 10.1007/s00277-012-1558-3. Epub 2012 Aug 30.
6
Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept.接受罗特西普治疗的β地中海贫血女性的意外妊娠
Br J Haematol. 2024 Jun;204(6):2505-2507. doi: 10.1111/bjh.19480. Epub 2024 Apr 23.
7
New partners for Luspatercept in β-thalassemia.鲁司帕西（Luspatercept）在β地中海贫血治疗中的新合作伙伴。
Am J Hematol. 2024 Jul;99(7):1217-1219. doi: 10.1002/ajh.27362. Epub 2024 May 16.
8
Oral iron chelation therapy for thalassaemia: an uncertain scene.地中海贫血的口服铁螯合疗法：前景不明。
Br J Haematol. 2000 Oct;111(1):2-5. doi: 10.1046/j.1365-2141.2000.02406.x.
9
Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.非转铁蛋白结合的不稳定血浆铁和镰状细胞病中的铁过载：镰状细胞病与β地中海贫血病患者的对比研究。
Eur J Haematol. 2010 Jan 1;84(1):72-8. doi: 10.1111/j.1600-0609.2009.01342.x.
10
Luspatercept: First Approval.芦帕他赛：首次批准
Drugs. 2020 Jan;80(1):85-90. doi: 10.1007/s40265-019-01251-5.
引用本文的文献
1
COVID-19 Antibody Response in Patients with Thalassemia.地中海贫血患者的新冠病毒抗体反应
Cureus. 2023 Jun 17;15(6):e40567. doi: 10.7759/cureus.40567. eCollection 2023 Jun.
2
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.患有血红蛋白病的意大利患者因感染SARS-CoV-2导致年龄标准化致死率增加了5倍。
Am J Hematol. 2022 Feb 1;97(2):E75-E78. doi: 10.1002/ajh.26429. Epub 2021 Dec 10.
本文引用的文献
1
β-Thalassemias.β地中海贫血
N Engl J Med. 2021 Feb 25;384(8):727-743. doi: 10.1056/NEJMra2021838.
2
Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience.地中海贫血患者的2019冠状病毒病（COVID-19）严重程度：伊朗全国范围的经验
Mediterr J Hematol Infect Dis. 2021 Jan 1;13(1):e2021008. doi: 10.4084/MJHID.2021.008. eCollection 2021.
3
Vitamin and mineral supplementation for β-thalassemia during COVID-19 pandemic.新冠疫情期间β地中海贫血的维生素和矿物质补充
Future Sci OA. 2020 Aug 18;6(9):FSO628. doi: 10.2144/fsoa-2020-0110.
4
The impact of COVID-19 on transfusion-dependent thalassemia patients of Karachi, Pakistan: A single-center experience.COVID-19 对巴基斯坦卡拉奇依赖输血的地中海贫血症患者的影响：单中心经验。
Transfus Clin Biol. 2021 Feb;28(1):60-67. doi: 10.1016/j.tracli.2020.10.006. Epub 2020 Oct 19.
5
The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19.ABO 血型与 COVID-19 疾病严重程度和多器官功能障碍指标的关联。
Blood Adv. 2020 Oct 27;4(20):4981-4989. doi: 10.1182/bloodadvances.2020002623.
6
Reduced prevalence of SARS-CoV-2 infection in ABO blood group O.O 型血人群 SARS-CoV-2 感染率降低。
Blood Adv. 2020 Oct 27;4(20):4990-4993. doi: 10.1182/bloodadvances.2020002657.
7
A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we stand.地中海贫血患者中 COVID-19 的 ICET-A 网络全面更新：我们所知及现状
Acta Biomed. 2020 Sep 7;91(3):e2020026. doi: 10.23750/abm.v91i3.10063.
8
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.肥胖与 COVID-19 患者：流行病学和生物学关系的全球视角。
Obes Rev. 2020 Nov;21(11):e13128. doi: 10.1111/obr.13128. Epub 2020 Aug 26.
9
Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study.血红蛋白病患者新冠病毒病的初步数据：一项多中心ICET-A研究
Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020046. doi: 10.4084/MJHID.2020.046. eCollection 2020.
10
COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation.COVID-19 与地中海贫血：国际地中海贫血联盟立场声明。
Eur J Haematol. 2020 Oct;105(4):378-386. doi: 10.1111/ejh.13476. Epub 2020 Jul 13.
Zotero 插件